These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7026294)

  • 1. Clinical and hormonal studies in hyperthecosis of the ovaries.
    Nagamani M; Lingold JC; Gomez LG; Garza JR
    Fertil Steril; 1981 Sep; 36(3):326-32. PubMed ID: 7026294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia in hyperthecosis of the ovaries.
    Nagamani M; Van Dinh T; Kelver ME
    Am J Obstet Gynecol; 1986 Feb; 154(2):384-9. PubMed ID: 3511712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral and Ovarian Steroids in Ovarian Hyperthecosis.
    Abraham GE; Buster JE
    Obstet Gynecol; 1976 May; 47(5):581-6. PubMed ID: 1264403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
    Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to constant infusion of LH-RH in girls with primary hypogonadism.
    Reiter EO; Duckett GE; Root AW
    Obstet Gynecol; 1980 Sep; 56(3):339-43. PubMed ID: 6448363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive edema of the ovary and virilization.
    Vasquez SB; Sotos JF; Kim MH
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):95S-9S. PubMed ID: 6283445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL; Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty.
    Genazzani AR; Pintor C; Facchinetti F; Faedda A; Corda R; Fioretti P
    J Endocrinol Invest; 1978 Apr; 1(2):115-9. PubMed ID: 158605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone.
    Parker CR; Bruneteau DW; Greenblatt RB; Mahesh VB
    Fertil Steril; 1975 Sep; 26(9):877-88. PubMed ID: 126875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
    Lucisano A; Acampora MG; Russo N; Maniccia E; Montemurro A; Dell'Acqua S
    Maturitas; 1984 Jul; 6(1):45-53. PubMed ID: 6472127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
    van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
    Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine studies of normal and polycystic ovarian tissues in vitro.
    Wilson EA; Erickson GF; Zarutski P; Finn AE; Tulchinsky D; Ryan KJ
    Am J Obstet Gynecol; 1979 May; 134(1):56-63. PubMed ID: 220877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral steroid levels in a patient with virilizing adrenal adenoma.
    Chakmakjian ZH; Abraham GE
    Obstet Gynecol; 1975 Nov; 46(5):544-8. PubMed ID: 127956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral steroid levels in a patient with congenital absence of the uterus.
    Chang RJ; Abraham GE
    Obstet Gynecol; 1975 Sep; 46(3):320-22. PubMed ID: 125866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and ovarian parameters at various frequencies of ovulation in adolescents.
    Venturoli S; Fabbri R; Porcu E; Paradisi R; Orsini LF; Brondelli L; Ruggeri S; Flamigni C
    Arch Gynecol Obstet; 1989; 246(2):107-14. PubMed ID: 2510614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.